Brief: Carsgen Therapeutics Executes Collaboration Agreement With F. Hoffmann-La Roche
Jan 31 (Reuters) - CARsgen Therapeutics Holdings Ltd
2171.HK :
* EXECUTION OF COLLABORATION AGREEMENT WITH F. HOFFMANN-LA
ROCHE
TO EVALUATE CARSGEN ' S INVESTIGATIONAL DRUG AB011
* UNDER AGREEMENT ROCHE WILL BE RESPONSIBLE FOR OPERATION &
CONDUCT OF TRIAL WHILE BOTH COS CO-SHARE COSTS OF AB011
TREATMENT ARMS
Source text for Eikon: ID:nHKS40gtCR
Further company coverage: 2171.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer